Oryzon Genomics

Oncology

Carlos Buesa, CEO of Oryzon Genomics, discusses exploring how epigenetics is reshaping the landscape of oncology and CNS therapies.

News

The WHO has held a closed expert meeting to identify potential vaccines for the Bundibugyo species of Ebola and fast-track clinical trials.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.